We deliver daily stock analysis focused on earnings performance, price trends, and institutional activity, helping users track market opportunities across major US-listed companies.
As of 2026-04-08, Keros Therapeutics Inc. (KROS) is trading at a current price of $12.5, marking a 2.12% gain on the day. This analysis examines key technical levels, recent market context, and potential future scenarios for the biotech stock, with no recent earnings data available for the company as of this publication. KROS has seen relatively range-bound trading in recent weeks, with price action largely tied to broader biotech sector flows rather than company-specific news. Key takeaways for
Is Keros Therapeutics (KROS) Stock heavily shorted | Price at $12.50, Up 2.12% - Weekly Profile
KROS - Stock Analysis
3605 Comments
503 Likes
1
Kaizley
Experienced Member
2 hours ago
{协议答案}
👍 59
Reply
2
King
Registered User
5 hours ago
{协议答案}
👍 56
Reply
3
Ilirida
Returning User
1 day ago
{协议答案}
👍 147
Reply
4
Orleen
Regular Reader
1 day ago
{协议答案}
👍 179
Reply
5
Alesandro
Expert Member
2 days ago
{协议答案}
👍 285
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.